全文获取类型
收费全文 | 34305篇 |
免费 | 2114篇 |
国内免费 | 819篇 |
专业分类
耳鼻咽喉 | 490篇 |
儿科学 | 1519篇 |
妇产科学 | 522篇 |
基础医学 | 2411篇 |
口腔科学 | 258篇 |
临床医学 | 4180篇 |
内科学 | 4487篇 |
皮肤病学 | 178篇 |
神经病学 | 1864篇 |
特种医学 | 1610篇 |
外国民族医学 | 3篇 |
外科学 | 7460篇 |
综合类 | 4626篇 |
现状与发展 | 2篇 |
预防医学 | 2469篇 |
眼科学 | 210篇 |
药学 | 2873篇 |
20篇 | |
中国医学 | 832篇 |
肿瘤学 | 1224篇 |
出版年
2024年 | 28篇 |
2023年 | 503篇 |
2022年 | 824篇 |
2021年 | 1276篇 |
2020年 | 1243篇 |
2019年 | 1174篇 |
2018年 | 1168篇 |
2017年 | 1072篇 |
2016年 | 1190篇 |
2015年 | 1228篇 |
2014年 | 2495篇 |
2013年 | 2316篇 |
2012年 | 1991篇 |
2011年 | 2138篇 |
2010年 | 1706篇 |
2009年 | 1726篇 |
2008年 | 1735篇 |
2007年 | 1694篇 |
2006年 | 1568篇 |
2005年 | 1342篇 |
2004年 | 1146篇 |
2003年 | 914篇 |
2002年 | 838篇 |
2001年 | 739篇 |
2000年 | 536篇 |
1999年 | 520篇 |
1998年 | 420篇 |
1997年 | 345篇 |
1996年 | 321篇 |
1995年 | 294篇 |
1994年 | 253篇 |
1993年 | 253篇 |
1992年 | 243篇 |
1991年 | 203篇 |
1990年 | 187篇 |
1989年 | 167篇 |
1988年 | 150篇 |
1987年 | 140篇 |
1986年 | 148篇 |
1985年 | 177篇 |
1984年 | 133篇 |
1983年 | 93篇 |
1982年 | 139篇 |
1981年 | 99篇 |
1980年 | 75篇 |
1979年 | 57篇 |
1978年 | 69篇 |
1977年 | 49篇 |
1976年 | 30篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
42.
目的 研究海绵共附生真菌Fusarium equiseti SCSIO 41019的次级代谢产物及抑菌活性。方法 采用中压硅胶柱色谱、中压反相ODS柱色谱及高效液相色谱等方法对发酵产物进行分离和纯化,运用核磁数据及文献对比的方法鉴定化合物结构。采用滤纸片琼脂扩散法、改良肉汤稀释法评价化合物的抑菌活性。结果 从其大米发酵产物中分离并鉴定了8个化合物,分别为equisetin(1)、5'-epiequisetin(2)、lumichrome(3)、N-乙酰基色胺(4)、亚油酸(5)、methyl (4-hydroxyphenyl) acetate(6)、methyl (2-hydroxyphenyl) acetate(7)和graminin B(8)。化合物1、2和5对金黄色葡萄球菌(Staphylococcus aureus)和耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus, MRSA)分别具有不同程度的抑制作用,最小抑菌浓度(minimal inhibitory concentration, MIC)为2.0~125μg/mL,其中化合物1的抑菌活性最强(MIC值分别为2.0和3.9μg/mL)。结论 从菌株Fusarium equiseti SCSIO 41019分离得到两个具良好抑菌活性的化合物(1~2),为将其开发为耐甲氧西林金黄色葡萄球菌的先导化合物提供一定参考。 相似文献
43.
44.
45.
IntroductionOne of the current harm reduction debates in Australia concerns the legalisation of the extended distribution of sterile needles and syringes, a practice that is currently unlawful in most Australian settings.MethodsWe used data from a unique pilot program of authorised extended distribution to document the opinions held by 22 key stakeholders -service staff, drug users and police - about the risks and benefits of authorisation, and to analyse the ways in which drug users were understood within these.ResultsOpinions were strongly in favour of authorising extended distribution, based on the belief that this would reduce the transmission of hepatitis C. However, stakeholders also identified that distributors risked attention from police and some noted that the consequences of this would be borne by distributors themselves and not the services that support them. These opinions rested on specific assumptions about people who inject, some of which reflect negative constructions of drug users as a source of danger to the public or as helpless ‘addicts’ with little control over their risk reduction. But there were other representations that positioned drug users more positively as responsible agents with a strong duty of care to themselves and others whose choices are often limited by inadequate service structures. Staff participants drew on these understandings in careful and strategic ways, arguing for the rationality and expertise of drug users, while also problematizing the individualised approach that any form of authorised extended distribution might take.ConclusionWe argue that localised and incremental changes such as those that took place to support this pilot project, and the extensive support for extended distribution among stakeholders in this study including police, creates meaningful opportunities to think about extended distribution differently, which can in turn support conditions for future discussions about legislative change. 相似文献
46.
47.
48.
49.
《The Journal of arthroplasty》2020,35(2):544-549
BackgroundNew treatment algorithms for periprosthetic joint infections (PJIs) show high success rates in achieving permanent infection eradication with some degree of failure. Different salvage procedures are described, but there is no evidence for persistent fistula (PF). The purpose of this study was to analyze PF as a salvage procedure in patients with therapy-resistant PJIs.MethodsThis retrospective analysis included all patients treated with PF (2005-2018) in a maximum care center with PJI (knee or hip). The baseline parameters (age, sex, BMI) and other data (number of surgeries, pathogen spectrum, American Society of Anesthesiologists classification) were recorded. The function was documented using the Harris Hip Score, the Knee Society Score, and the quality of life using the SF-36 Health Survey.ResultsA total of 159 patients were included (80 ± 12 years) and subdivided into four groups: hip (n = 66), knee (n = 13), Girdlestone resection arthroplasty (n = 50), knee arthrodesis (n = 27). Patients stayed 111 ± 87 days in the hospital, underwent six operations and three revisions after establishing PF. The mean American Society of Anesthesiologists score was 2.7. The BMI was 31 ± 3 kg/m2 (P = .1). The follow-up was 2.8 ± 0.5 years including 27 patients. The Harris Hip Score and Knee Society Score were 38 and 34, respectively. SF-36 showed no significant difference.ConclusionThe study showed poor outcomes regarding quality of life and the function of the infected joint. Therefore, the indication for establishing a PF in the treatment of PJI must be assessed very critically. PF is only an option for multimorbid patients with a limited life expectancy. 相似文献
50.